TNFRSF11B and metabolic dysfunction-associated steatotic liver disease: In the clinical setting, most observational studies showed low OPG concentrations in metabolically healthy obesity and NAFLD, whereas high concentrations in T2DM, in which higher OPG was also associated with the severity of disease and diabetic complications.